RxDoctor Payments Data

Danielle Reynolds

Pediatric Endocrinology · Tampa, FLNPI 1154564631

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $7,200 of the $8,360 with a category attached, or 86.1%. 10 manufacturers reported payments, led by Ultragenyx Pharmaceutical Inc. at 57.6% of the total.

$8,360in general payments, 2019–2025

Across 24 payments — averaging $348.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ultragenyx Pharmaceutical Inc.$5K
  • AstraZeneca$3K
  • Ascendis Pharma Endocrinology Inc$220
  • Novo Nordisk$150
  • Amgen$98
  • Medtronic$91
  • plus $156 from 4 others
$1,127,281in research payments, 2019–2025

Across 220 payments — averaging $5124.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ultragenyx Pharmaceutical Inc.$1.1M
  • Amgen$40K
  • Pfizer$24K

What the payments were for

  • Consulting fees$7,20086%
  • Food & beverage$1,14514%
  • Education$150%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,360 in reported general payments places this provider in the 75th percentile of 102 pediatric endocrinology providers in Florida.

See all pediatric endocrinology providers in Florida

Other pediatric endocrinology in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →